<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a family heterozygous for a newly identified mutation in the tyrosine kinase I domain of the FGFR2 gene (1576A &gt; G, encoding the missense substitution Lys526Glu), associated with <z:hpo ids='HP_0003828'>variable expressivity</z:hpo> of <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon syndrome</z:e>, including clinical nonpenetrance </plain></SENT>
<SENT sid="1" pm="."><plain>Our observations expand both the clinical and molecular spectrum of this unusual subset of FGFR2 mutations </plain></SENT>
</text></document>